Starting January 1, 2023, the Indian government requires all Active Pharmaceutical Ingredients (APIs) manufactured in India to have QR codes. The reason for this government initiative is to help guarantee the quality and safety of APIs. Historically, about 20% of APIs made in India have been inadequate, counterfeit, or had other problems. The QR code should include the name of the API, brand name, address of the manufacturing company, expiration or retesting date, batch size, special storage conditions, as well as other information. Indian Pharmaceutical manufacturers can use digital interaction to implement QR codes which will lead to regulatory compliance.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.
Source used in the article: https://www.biospectrumindia.com/views/17/22391/adding-value-to-governments-mandated-qr-code-on-all-apis.html